Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection

Microbiology Spectrum(2022)10.1128/spectrum.00263-22Source: DataRank Database

Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.64)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Duolong Zhu ORCID,Xingmin Sun ORCID,Shaohui Wang ORCID

Live enrichment

PubMed:35583336 PMC:PMC9241731 OpenAlex:https://openalex.org/W4280513467

HHS | National Institutes of Health

Grant: R01-AI132711

HHS | National Institutes of Health

Grant: R01-AI149852

NIAID NIH HHS

Grant: R01 AI132711

NIAID NIH HHS

Grant: R01 AI149852

National Institutes of Health

Grant: 5R01AI149852-03

Novel polymer biomaterials combating C. difficile infection

National Institutes of Health

Grant: 5R01AI132711-07

Multivalent vaccines against Clostridioides difficile infection

FWCI

1.64

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.00263-22

publisherhttps://doi.org/10.1128/spectrum.00263-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.00263-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35583336

repositoryhttps://doaj.org/article/bbb97c1c4bd343128096d485bd97fdbc

Fields of Study

Clostridium difficile and Clostridium perfringens researchViral gastroenteritis research and epidemiologyMicroscopic Colitis0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsBacterial ProteinsBacterial ToxinsBacterial VaccinesClostridioidesClostridioides difficileClostridium InfectionsEnterotoxinsMiceVaccines, Synthetic

MeSH Terms

ClostridioidesAnimalsBacterial ProteinsBacterial ToxinsBacterial VaccinesClostridium InfectionsEnterotoxinsVaccines, SyntheticClostridioides difficileMice

Keywords

ClostridioidesMedicineMicrobiologyBiologyVirologySporeVaccineChimeric proteinOral immunizationClostridioides Difficile InfectionNontoxigenic Clostridioides DifficileVaccines, SyntheticClostridioides difficileBacterial ToxinsQR1-502EnterotoxinsMiceBacterial ProteinsBacterial VaccinesClostridium InfectionsAnimalsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)